Dahan A - Search Results

1

Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay.

Beig A, Miller JM, Lindley D, Carr RA, Zocharski P, Agbaria R, Dahan A. Beig A, et al. Among authors: dahan a. J Pharm Sci. 2015 Sep;104(9):2941-7. doi: 10.1002/jps.24496. Epub 2015 May 18. J Pharm Sci. 2015. PMID: 25989509

2

Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs.

Miller JM, Dahan A, Gupta D, Varghese S, Amidon GL. Miller JM, et al. Among authors: dahan a. J Control Release. 2009 Jul 1;137(1):31-7. doi: 10.1016/j.jconrel.2009.02.018. Epub 2009 Mar 2. J Control Release. 2009. PMID: 19264104

3

Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs.

Dahan A, Miller JM, Amidon GL. Dahan A, et al. AAPS J. 2009 Dec;11(4):740-6. doi: 10.1208/s12248-009-9144-x. Epub 2009 Oct 30. AAPS J. 2009. PMID: 19876745 Free PMC article. Review.

4

The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone.

Dahan A, Miller JM, Hoffman A, Amidon GE, Amidon GL. Dahan A, et al. J Pharm Sci. 2010 Jun;99(6):2739-49. doi: 10.1002/jps.22033. J Pharm Sci. 2010. PMID: 20039391 Free article.

5

Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir.

Miller JM, Dahan A, Gupta D, Varghese S, Amidon GL. Miller JM, et al. Among authors: dahan a. Mol Pharm. 2010 Aug 2;7(4):1223-34. doi: 10.1021/mp100050d. Mol Pharm. 2010. PMID: 20536260 Free PMC article.

6

High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.

Dahan A, Miller JM, Hilfinger JM, Yamashita S, Yu LX, Lennernäs H, Amidon GL. Dahan A, et al. Mol Pharm. 2010 Oct 4;7(5):1827-34. doi: 10.1021/mp100175a. Epub 2010 Sep 3. Mol Pharm. 2010. PMID: 20701326

7

Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality.

Sun J, Miller JM, Beig A, Rozen L, Amidon GL, Dahan A. Sun J, et al. Among authors: dahan a. Expert Opin Drug Metab Toxicol. 2011 Mar;7(3):313-23. doi: 10.1517/17425255.2011.550875. Epub 2011 Jan 14. Expert Opin Drug Metab Toxicol. 2011. PMID: 21235283 Review.

8

The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.

Miller JM, Beig A, Krieg BJ, Carr RA, Borchardt TB, Amidon GE, Amidon GL, Dahan A. Miller JM, et al. Among authors: dahan a. Mol Pharm. 2011 Oct 3;8(5):1848-56. doi: 10.1021/mp200181v. Epub 2011 Aug 11. Mol Pharm. 2011. PMID: 21800883

9

The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.

Miller JM, Beig A, Carr RA, Webster GK, Dahan A. Miller JM, et al. Among authors: dahan a. Mol Pharm. 2012 Mar 5;9(3):581-90. doi: 10.1021/mp200460u. Epub 2012 Feb 22. Mol Pharm. 2012. PMID: 22280478

10

Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption.

Beig A, Miller JM, Dahan A. Beig A, et al. Among authors: dahan a. Eur J Pharm Biopharm. 2012 Jun;81(2):386-91. doi: 10.1016/j.ejpb.2012.02.012. Epub 2012 Feb 24. Eur J Pharm Biopharm. 2012. PMID: 22387337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters